MedPath

Atgen Canada Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy

Not Applicable
Terminated
Conditions
Immunity, Innate
Colorectal Cancer
First Posted Date
2017-08-15
Last Posted Date
2023-01-31
Lead Sponsor
ATGen Canada Inc
Target Recruit Count
396
Registration Number
NCT03249727
Locations
🇨🇦

Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada

🇨🇦

McGill University and the McGill University Health Centre, Montreal, Quebec, Canada

🇨🇦

CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada

Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy

Not Applicable
Terminated
Conditions
Immunity, Innate
Prostatic Neoplasm
First Posted Date
2017-08-08
Last Posted Date
2019-07-05
Lead Sponsor
ATGen Canada Inc
Target Recruit Count
84
Registration Number
NCT03242265
Locations
🇨🇦

Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada

Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy

Not Applicable
Completed
Conditions
Natural Killer Cell Cytokine Production
First Posted Date
2014-11-14
Last Posted Date
2017-08-14
Lead Sponsor
ATGen Canada Inc
Target Recruit Count
1081
Registration Number
NCT02291198
Locations
🇨🇦

Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath